Reference pricing for medicines in Moldova: experience, challenges

Abstract

The main goal of creating a reference price system is to reduce the cost of medicines. Although the principles of reference pricing in European countries are a matter of debate, its use is becoming more widespread. The debate concerns such issues as the definition of market segments to which the reference system should be applied, the calculation of reimbursement levels, as well as the impact of the reference system on the pricing and marketing policies of pharmaceutical companies. Based on the experience of the Republic of Moldova, a deep analysis of the above-mentioned problems is appropriate in countries facing similar challenges.